Slagle Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$495K Sell
413
-4
-1% -$4.09K 0.15% 84
2026
Q1
$383K Sell
417
-128
-23% -$130K 0.13% 89
2025
Q4
$585K Buy
545
+154
+39% +$147K 0.2% 76
2025
Q3
$298K Buy
391
+4
+1% +$2.98K 0.11% 96
2025
Q2
$301K Buy
387
+6
+2% +$4.66K 0.12% 92
2025
Q1
$314K Hold
381
0.14% 79
2024
Q4
$294K Buy
381
+4
+1% +$3.31K 0.13% 84
2024
Q3
$334K Buy
377
+9
+2% +$8.09K 0.15% 83
2024
Q2
$333K Buy
368
+5
+1% +$4K 0.17% 82
2024
Q1
$283K Sell
363
-527
-59% -$375K 0.15% 88
2023
Q4
$259K Buy
890
+445
+100% +$260K 0.15% 95
2023
Q3
$239K Sell
445
-52
-10% -$26.8K 0.15% 101
2023
Q2
$233K Buy
+497
New +$208K 0.15% 110

Other funds holding LLY

Slagle Financial's LLY Position: Q2 2026 in Review

Slagle Financial reduced its Eli Lilly (LLY) stake by 0.96% in Q2 2026, selling an estimated $4.09K and leaving 413 shares worth $495K. The position accounts for 0.15% of the portfolio, ranked #84.

Slagle Financial first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $585K in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Slagle Financial held 413 shares of Eli Lilly worth $495K as of Q2 2026.
  • Slagle Financial sold 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.15% of Slagle Financial's portfolio in Q2 2026, its #84 holding.
  • Slagle Financial first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Slagle Financial's Eli Lilly position peaked at $585K in Q4 2025.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Slagle Financial's 13F filing for Q2 2026, filed 29 Jul 2026.